Albeit the United States Drug Enforcement Administration has kept to its word that it is vital to stop the growth of research cannabis to just one cultivator in order to not violate international drug laws, a new federal report shows that that the United State’s largest drug warriors have been wrong. The Drug Enforcement Administration actually does have the ability to give out more licenses and still be in compliance with the United Nation’s laws.
As an answer to a recent question from New York Senator Kirsten Gillibrand, the Bureau of International Narcotics and Law Enforcement at the United States Department of State states that there is no actual legal issue with giving out more licenses to grow cannabis for medical and research purposes.
“Nothing in the text of the Single Convention, nor in the Commentary, suggests that there is a limitation on the number of licenses that can be issued, nor, on the other hand, is there a prohibition against member states imposing such a limitation,” the report says. “Moreover, we are not aware that the International Narcotics Control Board has highlighted the number of licenses as an issue of concern.”
This report came from the State Department and went against the way the Drug Enforcement Administration has interpreted international law. This means that the cannabis monopoly that has been looked over by the National Institute on Drug Abuse has been useless. The State Department even makes it a point in its release that the marijuana monopoly does not need to be set up to be in line with international drug laws.
“With this news, President Obama should direct the DEA to immediately begin the process of issuing additional licenses,” Mike Liszewski, Director of Government Affairs for Americans for Safe Access, stated. “Breaking up the DEA-mandated NIDA monopoly would benefit researchers and patients alike, and would not offend treaty obligations.”
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
